Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Jefford

Showing results (21-30 of 231) with videos related to

Pageof 24
Sort By:
Expert Opinion on Investigational Drugs|July 12, 2005
Beyond 5-fluorouracil: new horizons in systemic therapy for advanced colorectal cancerKenneth Khamly, Michael Jefford, Michael Michael, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2007
Information about cancer clinical trials: an analysis of Internet resourcesCraig P Carden, Michael Jefford, Mark A Rosenthal
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2024
Shared Care Is an Appropriate Model for Many Cancer SurvivorsMichael Jefford, Raymond J Chan, Jon D Emery
Asia-Pacific Journal of Clinical Oncology|June 20, 2019
Identifying the most prevalent unmet needs of cancer survivors in Australia: A systematic reviewKarolina Lisy, Laura Langdon, Amanda Piper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
Appropriate, timely referral to palliative care services: a name change will not helpDonna Milne, Michael Jefford, Penelope Schofield, et al.
Expert Opinion on Investigational Drugs|January 26, 2006
Recent developments in the systemic therapy of advanced gastroesophageal malignanciesKenneth Khamly, Michael Jefford, Michael Michael, et al.
Acta Oncologica (Stockholm, Sweden)|January 3, 2017
How will cancer survivors use survivorship care plans?Nicole A Kinnane, Amanda J Piper, Michael Jefford
Journal of Leukocyte Biology|January 15, 2003
Rational approaches to human cancer immunotherapyIan D Davis, Michael Jefford, Phillip Parente, et al.
Cancers|June 2, 2021
How Do We Define and Measure Optimal Care for Cancer Survivors? An Online Modified Reactive Delphi StudyKarolina Lisy, Lena Ly, Helana Kelly, et al.
Patient Education and Counseling|September 29, 2009
Effectively discussing complementary and alternative medicine in a conventional oncology setting: communication recommendations for cliniciansPenelope Schofield, Justine Diggens, Catherine Charleson, et al.
Pageof 24

Showing results (21-30 of 231) with videos related to

Sort By:
Pageof 24
Expert Opinion on Investigational Drugs|July 12, 2005
Beyond 5-fluorouracil: new horizons in systemic therapy for advanced colorectal cancerKenneth Khamly, Michael Jefford, Michael Michael, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2007
Information about cancer clinical trials: an analysis of Internet resourcesCraig P Carden, Michael Jefford, Mark A Rosenthal
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2024
Shared Care Is an Appropriate Model for Many Cancer SurvivorsMichael Jefford, Raymond J Chan, Jon D Emery
Asia-Pacific Journal of Clinical Oncology|June 20, 2019
Identifying the most prevalent unmet needs of cancer survivors in Australia: A systematic reviewKarolina Lisy, Laura Langdon, Amanda Piper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
Appropriate, timely referral to palliative care services: a name change will not helpDonna Milne, Michael Jefford, Penelope Schofield, et al.
Expert Opinion on Investigational Drugs|January 26, 2006
Recent developments in the systemic therapy of advanced gastroesophageal malignanciesKenneth Khamly, Michael Jefford, Michael Michael, et al.
Acta Oncologica (Stockholm, Sweden)|January 3, 2017
How will cancer survivors use survivorship care plans?Nicole A Kinnane, Amanda J Piper, Michael Jefford
Journal of Leukocyte Biology|January 15, 2003
Rational approaches to human cancer immunotherapyIan D Davis, Michael Jefford, Phillip Parente, et al.
Cancers|June 2, 2021
How Do We Define and Measure Optimal Care for Cancer Survivors? An Online Modified Reactive Delphi StudyKarolina Lisy, Lena Ly, Helana Kelly, et al.
Patient Education and Counseling|September 29, 2009
Effectively discussing complementary and alternative medicine in a conventional oncology setting: communication recommendations for cliniciansPenelope Schofield, Justine Diggens, Catherine Charleson, et al.
Pageof 24